Cantuzumab ravtansine (ADC)
Produktgrößen
1 mg
£2294,00
DHD14298-1MG
5 mg
£7966,00
DHD14298-5MG
Über dieses Produkt
- SKU:
- DHD14298
- Zusätzliche Namen:
- C242-DM4
- translate.label.attr.clone:
- Cantuzumab ravtansine
- Klonalität:
- Monoclonal, Recombinant Monoclonal
- Konzentration:
- 1 mg/ml
- Weitere Details:
- Cantuzumab ravtansine is an ADC consisting of a CanAg-directed antibody and DM4 that has extensive antitumor efficacy in a series of CanAg-positive human tumor xenografts.
- Immunogen:
- PEMT, CA 15-3, H23AG, Peanut-reactive urinary mucin, PEM, EMA, Cancer antigen 15-3, MUC-1, Episialin, MUC1-CT, MUC1-beta, Tumor-associated mucin, CD227, Polymorphic epithelial mucin, KL-6, MUC1-alpha, MUC1, PUM, Krebs von den Lungen-6, MUC1-NT, Tumor-associated epithelial membrane antigen, Mucin-1, Breast carcinoma-associated antigen DF3, Carcinoma-associated mucin
- Physischer Zustand:
- Liquid
- Reinheit:
- >90% as determined by sec.
- Aufreinigung:
- Ion Exchange
- Reaktivitäten:
- Human
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- -20[o]C Avoid freeze/thaw cycles., 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Hersteller:
- AntibodySystem
- Typ:
- Antibody: Recombinant Antibodies